Celecoxib not riskier for heart than other NSAIDs

Celecoxib is no more likely to cause cardiovascular events than ibuprofen or naproxen, the PRECISION trial has found Before this trial, the cardiovascular safety of celecoxib as compared with nonselective nonsteroidal anti-inflammatory drugs had been uncertain. But the 10-year randomised, multicentre, double-blind, noninferiority PRECISION trial, which involved over 24,000 patients who were at increased cardiovascular